Travere Therapeutics Inc
NASDAQ:TVTX

Watchlist Manager
Travere Therapeutics Inc Logo
Travere Therapeutics Inc
NASDAQ:TVTX
Watchlist
Price: 35 USD -0.93% Market Closed
Market Cap: 3.1B USD

During the last 3 months Travere Therapeutics Inc insiders have not bought any shares, and sold 7.9m USD worth of shares. The stock price has increased by 65% over this period (open performance analysis).

The last transaction was made on Dec 1, 2025 by Cline Christopher R. (Chief Legal Officer) , who sold 700.2k USD worth of TVTX shares.

Last Transactions:
Cline Christopher R.
Chief Legal Officer
$-700.2k
Calvin Sandra
$-2.4m
Heerma Peter
$-195.7k
Coughlin Timothy
$-630.6k
Dube Eric M
$-817.1k
Heerma Peter
Chief Operating Officer
$-79.9k
Dube Eric M
President, Chief Executive Officer & Director
$-2.8m
Reed Elizabeth E
$-250k
Cline Christopher R.
$-2.3k
Cline Christopher R.
$-8.3k
Cline Christopher R.
$-8.1k
Inrig Jula
$-11.9k
Cline Christopher R.
$-37.6k
Dube Eric M
$-398.4k
Heerma Peter
$-37.3k
Rote William E.
$-67.3k
Reed Elizabeth E
$-103.6k
Cline Christopher R.
$-630.9
Rote William E.
$-122.4k
Heerma Peter
$-60.4k
Inrig Jula
$-60.4k
Reed Elizabeth E
$-188.2k
Calvin Sandra
$-250k
Dube Eric M
$-273.5k
Heerma Peter
$-76.9k
Baynes Roy D.
$-220k
Inrig Jula
$-21.4k
Reed Elizabeth E
$-177.1k
Cline Christopher R.
$-104.5k
Heerma Peter
$-103.9k
Inrig Jula
$-84.6k
Dube Eric M
$-1m
View All Transactions

During the last 3 months Travere Therapeutics Inc insiders have not bought any shares, and sold 7.9m USD worth of shares. The stock price has increased by 65% over this period (open performance analysis).

The last transaction was made on Dec 1, 2025 by Cline Christopher R. (Chief Legal Officer) , who sold 700.2k USD worth of TVTX shares.

Sold
0-3
months
7.9m USD
6
3-6
months
30.7k USD
2
6-9
months
644.7k USD
5
9-12
months
4m USD
8
Bought
0-3
months
0
0 USD
3-6
months
0
0 USD
6-9
months
0
0 USD
9-12
months
0
0 USD

Travere Therapeutics Inc
Insider Trading Chart

Travere Therapeutics Inc
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Travere Therapeutics Inc
Last Insider Transactions

Global
Insiders Monitor

Travere Therapeutics Inc
Glance View

Market Cap
3.1B USD
Industry
Biotechnology

Travere Therapeutics Inc., a biopharmaceutical trailblazer, has carved a niche in the healthcare landscape by focusing on the often-overlooked realm of rare diseases. With a mission to improve the lives of patients grappling with conditions that lack sufficient treatment options, Travere leverages its deep expertise in research, development, and commercialization of therapies. Beyond generic pharmaceuticals, the company's extensive pipeline is filled with innovative treatments, targeting conditions from chronic kidney diseases to rare liver disorders. This strategic emphasis on rare diseases not only exemplifies Travere's commitment to social responsibility but also positions it uniquely within the competitive pharmaceutical sector, where the rarity of these conditions often results in limited competition. The financial lifeline of Travere Therapeutics comes from its ability to navigate the intricate process of bringing drugs from conception to market. Revenue streams are primarily driven by the sales of FDA-approved products, alongside milestone and royalty payments tied to strategic collaborations. The company’s shrewd strategy involves acquiring or licensing promising compounds and utilizing its robust in-house capabilities to carry these assets through clinical trials. This intertwined web of internal development and strategic partnerships creates a sustainable business model. It ensures that as current treatments mature and stabilize their market presence, new pipeline products are continually groomed, keeping revenue streams dynamic while reinforcing their commitment to addressing unmet medical needs.

TVTX Intrinsic Value
44.92 USD
Undervaluation 22%
Intrinsic Value
Price

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top